EAR - Eargo, Inc. Stock Price, Fair Value and News

75.60USD-1.05 (-1.37%)Delayed as of 22 Apr 2024, 08:27 am ET

Market Summary

USD75.60-1.05

Delayedas of 22 Apr 2024, 08:27 am

-1.37%

EAR Stock Price

View Fullscreen

EAR RSI Chart

EAR Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

-15.12

Price/Sales (Trailing)

39.8

EV/EBITDA

-15.41

Price/Free Cashflow

-21.57

EAR Price/Sales (Trailing)

EAR Profitability

EBT Margin

-262.90%

Return on Equity

-239.7%

Return on Assets

-155.08%

Free Cashflow Yield

-4.64%

EAR Fundamentals

EAR Revenue

Revenue (TTM)

41.1M

Rev. Growth (Yr)

4.58%

Rev. Growth (Qtr)

EAR Earnings

Earnings (TTM)

-108.2M

Earnings Growth (Yr)

65.77%

Earnings Growth (Qtr)

31.11%

Breaking Down EAR Revenue

52 Week Range

75.60

(Low)(High)

Last 7 days

-9.2%

Last 30 days

0.2%

Last 90 days

39.4%

Trailing 12 Months

92.6%

How does EAR drawdown profile look like?

EAR Financial Health

Current Ratio

3.22

Debt/Equity

0.23

Debt/Cashflow

-7.27

EAR Investor Care

Shares Dilution (1Y)

953.63%

Diluted EPS (TTM)

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	39.9M	40.7M	41.1M	0
2022	32.9M	33.6M	34.4M	37.2M
2021	78.5M	85.5M	58.8M	32.1M
2020	41.9M	51.0M	60.1M	69.2M
2019	0	0	28.0M	32.8M
2018	0	0	0	23.2M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Eargo, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 16, 2024	thorpe mark	back to issuer	-	-	-32.00	cfo & cao
Feb 16, 2024	wu david james	back to issuer	-	-	-25,463	-
Feb 16, 2024	brownie william	back to issuer	-	-	-296	interim ceo & coo
Nov 29, 2023	thorpe mark	back to issuer	-2,665	2.59	-1,029	chief accounting officer
Nov 20, 2023	laponis adam	back to issuer	-85.8	2.6	-33.00	chief financial officer
Nov 17, 2023	thorpe mark	back to issuer	-7.68	2.56	-3.00	chief accounting officer
Nov 17, 2023	brownie william	back to issuer	-35.84	2.56	-14.00	interim ceo & coo
Nov 17, 2023	laponis adam	back to issuer	-48.64	2.56	-19.00	chief financial officer
Nov 15, 2023	laponis adam	back to issuer	-7,247	2.55	-2,842	chief financial officer
Nov 13, 2023	brownie william	back to issuer	-16,510	2.55226	-6,469	interim ceo & coo

Which funds bought or sold EAR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 15, 2024	ATLAS CAPITAL ADVISORS LLC	sold off	-100	-3,167	-	-%
Mar 11, 2024	VANGUARD GROUP INC	added	2.37	40,413	223,040	-%
Feb 15, 2024	Nantahala Capital Management, LLC	new	-	2,567,110	2,567,110	0.08%
Feb 14, 2024	MILLENNIUM MANAGEMENT LLC	sold off	-100	-27,568	-	-%
Feb 14, 2024	CITADEL ADVISORS LLC	new	-	26,874	26,874	-%
Feb 14, 2024	Royal Bank of Canada	added	101	2,000	3,000	-%
Feb 14, 2024	CSS LLC/IL	sold off	-100	-18,249	-	-%
Feb 14, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	sold off	-100	-110,000	-	-%
Feb 14, 2024	TWO SIGMA SECURITIES, LLC	new	-	43,989	43,989	-%

Are Funds Buying or Selling EAR?

Are funds buying EAR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own EAR

No. of Funds

Unveiling Eargo, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 16, 2024	psc echo, lp	0%	0	SC 13D/A
Oct 30, 2023	psc echo, lp	76.3%	15,821,299	SC 13D/A
Jan 06, 2023	blackrock inc.	1.5%	6,090,500	SC 13G/A
Dec 16, 2022	nan fung group holdings ltd	0.7%	2,958,099	SC 13D/A
Dec 12, 2022	new enterprise associates 15, l.p.	-	0	SC 13D/A
Dec 07, 2022	blackrock inc.	16.1%	6,338,762	SC 13G
Dec 07, 2022	psc echo, lp	76.3%	316,425,980	SC 13D/A
Dec 05, 2022	psc echo, lp	76.3%	316,425,980	SC 13D
Oct 13, 2022	gilde healthcare holding b.v.	4.75%	1,869,290	SC 13D/A
Oct 11, 2022	gilde healthcare holding b.v.	5.38%	2,119,290	SC 13D/A

Recent SEC filings of Eargo, Inc.

View All Filings

Date Filed	Form Type	Document
Feb 26, 2024	15-12G	15-12G
Feb 21, 2024	S-8 POS	Employee Benefits Plan
Feb 21, 2024	S-8 POS	Employee Benefits Plan
Feb 21, 2024	S-8 POS	Employee Benefits Plan
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading

Peers (Alternatives to Eargo, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.2B	40.1B	-3.77%	-2.76%	32.53	4.64	-8.12%	-17.45%
BDX	67.7B	19.5B	-1.53%	-10.57%	53.87	3.47	4.02%	-22.04%
ALGN	22.5B	3.9B	-9.16%	-15.16%	50.45	5.81	3.42%	23.09%
BAX	20.0B	14.8B	-5.62%	-8.72%	7.55	1.35	2.12%	209.17%
MID-CAP
ATR	9.2B	3.5B	-0.49%	17.01%	32.33	2.64	4.97%	18.89%
HSIC	9.1B	12.3B	-5.22%	-14.61%	21.9	0.74	-2.44%	-22.68%
BIO	8.2B	2.7B	-16.90%	-39.13%	-12.81	3.06	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.41%	-25.34%	-47.02	1.6	1.10%	85.84%
AXNX	3.4B	366.4M	-2.66%	12.41%	-562.64	9.32	33.86%	89.83%
PDCO	2.3B	6.6B	-4.93%	-3.92%	12.05	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.2B	3.2B	-14.38%	-20.49%	-1.83	0.39	7.73%	-1066.14%
ANIK	383.7M	166.7M	0.86%	-5.21%	-4.64	2.3	6.67%	-456.34%
ANGO	250.7M	324.0M	11.81%	-29.38%	-1.3	0.77	-3.19%	-337.41%
APYX	45.7M	52.3M	-28.65%	-55.25%	-2.44	0.87	17.61%	19.28%
AEMD	3.8M	3.7M	-10.98%	147.46%	-0.31	1.02	5.77%	8.23%

Eargo, Inc. News

Latest updates

Eargo, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2018Q4
Revenue	2.0%	8,270,000	8,108,000	11,813,000	12,917,000	7,908,000	7,247,000	9,176,000	10,060,000	16,471,500	22,883,000	22,048,000	22,378,000	18,186,000	15,921,000	12,669,000	10,199,500	7,730,000	-
Gross Profit	165.7%	4,333,000	1,631,000	5,122,000	6,160,000	1,901,000	2,514,000	3,685,000	2,415,000	-30,421,000	16,421,000	15,751,000	15,800,000	12,752,000	10,716,000	8,013,000	-	4,147,000	-
Operating Expenses	-18.8%	22,281,000	27,437,000	27,914,000	30,044,000	27,947,000	33,957,000	34,071,000	47,643,000	48,627,000	35,483,000	29,120,000	25,725,000	20,388,000	16,293,000	19,746,000	-	16,192,000	-
S&GA Expenses	-26.5%	9,281,000	12,627,000	13,401,000	15,641,000	11,282,000	12,734,000	13,290,000	22,557,000	24,444,000	21,903,000	16,855,000	15,484,000	12,354,000	10,828,000	10,859,000	-	9,290,000	-
R&D Expenses	-11.6%	4,742,000	5,364,000	4,605,000	4,124,000	4,963,000	3,879,000	5,847,000	8,010,000	7,296,000	5,148,000	4,778,000	4,157,000	2,871,000	2,208,000	2,809,000	-	3,219,000	-
EBITDA Margin	24.6%	-2.51	-3.33	-3.58	-4.06	-4.45	-5.39	-5.13	-4.75	-2.03	-0.59	-0.47	-0.51	-0.70	-	-	-	-	-
Interest Expenses	-	-	-	-	-	-	285,000	264,000	270,000	269,000	266,000	263,000	498,000	279,000	877,000	266,000	-	218,000	-
Income Taxes	-	-	-	-	-	-	-	-	-84,000	-238,000	146,000	176,000	-	-	-	-	-	-	-
Earnings Before Taxes	31.1%	-17,328,000	-25,152,000	-21,922,000	-43,671,000	-50,627,000	-32,444,000	-30,645,000	-45,496,000	-79,315,000	-19,322,000	-13,621,000	-11,799,000	-9,726,000	-6,592,000	-11,738,000	-	-12,157,000	-
EBT Margin	24.2%	-2.63	-3.47	-3.73	-4.23	-4.63	-5.59	-5.32	-4.91	-2.11	-0.64	-0.53	-0.58	-0.74	-	-	-	-	-
Net Income	31.1%	-17,328,000	-25,152,000	-21,922,000	-43,771,000	-50,627,000	-32,444,000	-30,645,000	-45,496,000	-79,315,000	-19,322,000	-13,621,000	-11,799,000	-9,726,000	-6,592,000	-11,738,000	-13,347,000	-12,157,000	-
Net Income Margin	24.2%	-2.63	-3.47	-3.73	-4.23	-4.63	-5.59	-5.32	-4.91	-2.11	-0.64	-0.53	-0.58	-0.69	-	-	-	-	-
Free Cashflow	22.5%	-14,716,000	-18,996,000	-21,432,000	-20,702,000	-14,455,000	-63,903,000	-21,035,000	-45,131,000	-22,255,000	-22,347,000	-9,605,000	-6,769,000	-4,605,000	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Assets	-20.3%	70.00	88.00	115	132	117	150	136	160	201	216	224	233	88.00	27.00
Current Assets	-22.3%	57.00	73.00	98.00	116	99.00	133	117	140	180	201	213	222	77.00	20.00
Cash Equivalents	-24.3%	46.00	61.00	80.00	101	88.00	107	89.00	111	156	179	202	212	70.00	13.00
Inventory	-18.2%	4.00	5.00	5.00	5.00	5.00	7.00	6.00	6.00	6.00	3.00	2.00	3.00	3.00	3.00
Net PPE	-4.4%	4.00	5.00	6.00	7.00	9.00	8.00	9.00	10.00	10.00	10.00	9.00	8.00	7.00	5.00
Goodwill	-100.0%	-	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	-	-	-	-
Liabilities	-11.2%	25.00	28.00	32.00	31.00	153	139	94.00	91.00	98.00	40.00	38.00	39.00	37.00	31.00
Current Liabilities	-14.3%	18.00	21.00	25.00	25.00	147	132	77.00	72.00	78.00	24.00	23.00	24.00	21.00	22.00
Long Term Debt	-	-	-	-	-	-	-	10.00	12.00	13.00	15.00	15.00	15.00	15.00	7.00
LT Debt, Current	-	-	-	-	-	-	-	5.00	3.00	2.00	-	-	-	-	5.00
LT Debt, Non Current	-	-	-	-	-	-	-	10.00	12.00	13.00	15.00	15.00	15.00	15.00	7.00
Shareholder's Equity	-24.6%	45.00	60.00	82.00	101	-	11.00	42.00	69.00	103	176	186	194	-	-
Retained Earnings	-3.1%	-578	-561	-536	-514	-470	-419	-387	-356	-311	-232	-212	-199	-187	-159
Additional Paid-In Capital	0.4%	624	621	619	615	434	431	429	426	414	408	399	393	16.00	3.00
Shares Outstanding	0.1%	21.00	21.00	21.00	21.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	0.00	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2018Q4
Cashflow From Operations	21.9%	-14,737	-18,860	-21,330	-20,442	-13,980	-62,532	-20,350	-44,957	-22,093	-22,097	-9,309	-5,989	-4,068	-6,437	-9,547	-	-	-
Share Based Compensation	0.4%	2,640	2,629	3,408	2,373	3,057	1,550	2,985	11,881	5,478	5,241	5,131	2,726	1,367	471	525	-	-	-
Cashflow From Investing	86.1%	-19.00	-137	-132	-260	-475	-1,410	-942	-1,017	-1,172	-4,028	-1,370	-1,634	-1,270	-951	-1,224	-	-	-
Cashflow From Financing	-	-	-	-	33,865	-4,100	81,340	24.00	32.00	353	3,855	118	149,584	67,284	5,400	7,653	-	-	-

EAR Income Statement

2023-09-30

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue, net	$ 8,270	$ 7,908	$ 28,191	$ 24,331
Cost of revenue	3,937	6,007	17,105	16,231
Gross profit	4,333	1,901	11,086	8,100
Operating expenses:
Research and development	4,742	4,963	14,711	14,689
Sales and marketing	9,281	11,282	35,309	37,306
General and administrative	7,385	11,702	26,739	43,980
Impairment charge	873	0	873	0
Total operating expenses	22,281	27,947	77,632	95,975
Loss from operations	(17,948)	(26,046)	(66,546)	(87,875)
Other income (expense), net:
Interest income	620	419	2,144	480
Interest expense				(549)
Change in fair value of convertible notes		(25,000)		(25,000)
Loss on extinguishment of debt				(772)
Total other income (expense), net	620	(24,581)	2,144	(25,841)
Loss before income taxes	(17,328)	(50,627)	(64,402)	(113,716)
Net loss and comprehensive loss	(17,328)	(50,627)	(64,402)	(113,716)
Net loss attributable to common stockholders, basic and diluted	$ (17,328)	$ (50,627)	$ (64,402)	$ (113,716)
Net loss per share attributable to common stockholders, basic	$ (0.83)	$ (25.7)	$ (3.1)	$ (57.78)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic	20,756,123	1,969,856	20,745,534	1,968,074
Net loss per share attributable to common stockholders, diluted	$ (0.83)	$ (25.7)	$ (3.1)	$ (57.78)
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted	20,756,123	1,969,856	20,745,534	1,968,074

EAR Balance Sheet

2023-09-30

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 46,023	$ 101,238
Accounts receivable, net	1,012	1,910
Inventories	4,386	5,036
Prepaid expenses and other current assets	5,271	7,846
Total current assets	56,692	116,030
Operating lease right-of-use assets	7,327	5,765
Property and equipment, net	4,384	7,441
Intangible assets, net	744	1,063
Goodwill		873
Other assets	606	906
Total assets	69,753	132,078
Current liabilities:
Accounts payable	5,047	6,504
Accrued expenses	6,818	12,715
Sales returns reserve	3,767	3,942
Other current liabilities	1,338	1,462
Lease liability, current portion	624	628
Total current liabilities	17,594	25,251
Lease liability, noncurrent portion	7,030	5,973
Total liabilities	24,624	31,224
Commitments and contingencies (Note 5)
Stockholders' equity:
Common stock; $0.0001 par value; 450,000,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; 20,762,389 and 20,726,965 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	2	2
Additional paid-in capital	623,828	615,151
Accumulated deficit	(578,701)	(514,299)
Total stockholders' equity	45,129	100,854
Total liabilities and stockholders' equity	$ 69,753	$ 132,078

About Eargo, Inc.

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

CEO	Mr. William H. Brownie
WEBSITE	https://eargo.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	243

Eargo, Inc. Frequently Asked Questions

What is the ticker symbol for Eargo, Inc.? What does EAR stand for in stocks?

EAR is the stock ticker symbol of Eargo, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Eargo, Inc. (EAR)?

As of Fri Apr 19 2024, market cap of Eargo, Inc. is 1.59 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EAR stock?

You can check EAR's fair value in chart for subscribers.

What is the fair value of EAR stock?

You can check EAR's fair value in chart for subscribers. The fair value of Eargo, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Eargo, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for EAR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Eargo, Inc. a good stock to buy?

The fair value guage provides a quick view whether EAR is over valued or under valued. Whether Eargo, Inc. is cheap or expensive depends on the assumptions which impact Eargo, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EAR.

What is Eargo, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, EAR's PE ratio (Price to Earnings) is -15.12 and Price to Sales (PS) ratio is 39.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EAR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Eargo, Inc.'s stock?

In the past 10 years, Eargo, Inc. has provided 0.139 (multiply by 100 for percentage) rate of return.